EP Patent

EP0573271A1 — Angiotensin II antagonists

Assigned to Eli Lilly and Co · Expires 1993-12-08 · 32y expired

What this patent protects

This invention provides pharmaceutical phenyl and heterocyclic derivatives of the formula They antagonize angiotensin II receptors in mammals.

USPTO Abstract

This invention provides pharmaceutical phenyl and heterocyclic derivatives of the formula They antagonize angiotensin II receptors in mammals.

Drugs covered by this patent

nirogacestat-hydrobromide (NIROGACESTAT HYDROBROMIDE)

Patent Metadata

Patent number: EP0573271A1
Jurisdiction: EP
Classification: —
Expires: 1993-12-08
Drug substance claim: No
Drug product claim: No
Assignee: Eli Lilly and Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.